{"disease":{"id":"head-and-neck-paraganglioma","name":"head and neck paraganglioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06479811","title":"[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05942482","title":"Head and Neck Paragangliomas: A 16-year Experience of a University Hospital in Turkey","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Pamukkale University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}